医学
传输(电信)
感染控制
重症监护医学
大流行
防毒面具
接种疫苗
医疗保健
呼吸系统
急诊医学
2019年冠状病毒病(COVID-19)
免疫学
内科学
疾病
传染病(医学专业)
电气工程
经济增长
工程类
经济
复合材料
材料科学
作者
Marie-Céline Zanella,Chanu Rhee,Michael Klompas
标识
DOI:10.1097/qco.0000000000001115
摘要
Purpose of review The COVID-19 pandemic catalyzed new insights into respiratory viral transmission mechanisms and prevention. We review the most practical and impactful measures to prevent SARS-CoV-2 and other nosocomial respiratory viral infections in healthcare. Recent findings Nosocomial respiratory viral infection rates mirror viral activity levels in the surrounding community. During peak periods ∼15–20% of hospitalized patients with respiratory viral infections may have acquired their virus in the hospital. Nosocomial respiratory viral infections are associated with increased lengths-of-stay, risk of respiratory failure, and hospital death. Most procedures contribute minimally to aerosol production compared to labored breathing, coughing, and forced expiration. Masking for source control and exposure control both decrease transmission risk, respirators more so than masks. Likewise, vaccinating healthcare workers decreases transmission risk and is associated with lower patient mortality rates, particularly in long-term care facilities. Increasing air changes, ultraviolet irradiation, and portable HEPA filtration units may also decrease transmission rates but their marginal benefit relative to current healthcare ventilation standards has yet to be established. Summary Practical strategies to prevent nosocomial respiratory viral infections include maximizing staff and patient influenza and SARS-CoV-2 vaccination rates and implementing routine masking during patient interactions when community incidence is high.
科研通智能强力驱动
Strongly Powered by AbleSci AI